FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006974744> ?p ?o ?g. }

• W2006974744 endingPage "640" @default.
• W2006974744 startingPage "637" @default.
• W2006974744 abstract "The effect of azacitidine (AZA) in therapy related MDS and AML (t-MDS/AML) is not well established. 54 patients (42 t-MDS and 12 t-AML), 71% of whom had complex karyotype, received AZA for at least one cycle (median 4 cycles). The overall response rate (ORR) was 39% in the whole cohort and 62% in patients who received ≥4 cycles. One, 2 and 3 year OS was 36%, 14% and 8% respectively. Female gender (p=0.01) and ECOG 0-1 (p=0.04) were associated with significantly better OS, while karyotype and marrow blast percentage had no significant impact. By comparison with de novo MDS/AML treated in the same program, t-MDS/AML had a similar response rate (38% vs 45% in de novo MDS/AML, p=0.53), but significantly shorter OS (2 year OS of 14% vs 33.9%, p=0.0005). However, in a multivariate analysis performed in all patients (de novo and therapy related cases), only complex karyotype and high IPSS, and not etiology (i.e. de novo versus therapy related), had a significant impact on OS. Nine (15%) patients received allogeneic stem cell transplantation, 4 of whom were still alive." @default.
• W2006974744 created "2016-06-24" @default.
• W2006974744 creator A5001292844 @default.
• W2006974744 creator A5004876764 @default.
• W2006974744 creator A5007605254 @default.
• W2006974744 creator A5011803879 @default.
• W2006974744 creator A5012782675 @default.
• W2006974744 creator A5013766565 @default.
• W2006974744 creator A5014838075 @default.
• W2006974744 creator A5017435311 @default.
• W2006974744 creator A5025925500 @default.
• W2006974744 creator A5032208114 @default.
• W2006974744 creator A5053199721 @default.
• W2006974744 creator A5053724616 @default.
• W2006974744 creator A5067465993 @default.
• W2006974744 date "2013-06-01" @default.
• W2006974744 modified "2023-10-14" @default.
• W2006974744 title "Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM)" @default.
• W2006974744 cites W117509039 @default.
• W2006974744 cites W1856810180 @default.
• W2006974744 cites W187238933 @default.
• W2006974744 cites W1910981723 @default.
• W2006974744 cites W1994791499 @default.
• W2006974744 cites W1997314634 @default.
• W2006974744 cites W2015776863 @default.
• W2006974744 cites W2019634948 @default.
• W2006974744 cites W2029529782 @default.
• W2006974744 cites W2034160841 @default.
• W2006974744 cites W2070152906 @default.
• W2006974744 cites W2075049768 @default.
• W2006974744 cites W2097540657 @default.
• W2006974744 cites W2107398329 @default.
• W2006974744 cites W2118771330 @default.
• W2006974744 cites W2160820093 @default.
• W2006974744 cites W2464313871 @default.
• W2006974744 cites W2516371773 @default.
• W2006974744 cites W4232645703 @default.
• W2006974744 cites W4253916874 @default.
• W2006974744 doi "https://doi.org/10.1016/j.leukres.2013.02.014" @default.
• W2006974744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23499498" @default.
• W2006974744 hasPublicationYear "2013" @default.
• W2006974744 type Work @default.
• W2006974744 sameAs 2006974744 @default.
• W2006974744 citedByCount "46" @default.
• W2006974744 countsByYear W20069747442013 @default.
• W2006974744 countsByYear W20069747442014 @default.
• W2006974744 countsByYear W20069747442015 @default.
• W2006974744 countsByYear W20069747442016 @default.
• W2006974744 countsByYear W20069747442017 @default.
• W2006974744 countsByYear W20069747442018 @default.
• W2006974744 countsByYear W20069747442019 @default.
• W2006974744 countsByYear W20069747442020 @default.
• W2006974744 countsByYear W20069747442021 @default.
• W2006974744 countsByYear W20069747442022 @default.
• W2006974744 countsByYear W20069747442023 @default.
• W2006974744 crossrefType "journal-article" @default.
• W2006974744 hasAuthorship W2006974744A5001292844 @default.
• W2006974744 hasAuthorship W2006974744A5004876764 @default.
• W2006974744 hasAuthorship W2006974744A5007605254 @default.
• W2006974744 hasAuthorship W2006974744A5011803879 @default.
• W2006974744 hasAuthorship W2006974744A5012782675 @default.
• W2006974744 hasAuthorship W2006974744A5013766565 @default.
• W2006974744 hasAuthorship W2006974744A5014838075 @default.
• W2006974744 hasAuthorship W2006974744A5017435311 @default.
• W2006974744 hasAuthorship W2006974744A5025925500 @default.
• W2006974744 hasAuthorship W2006974744A5032208114 @default.
• W2006974744 hasAuthorship W2006974744A5053199721 @default.
• W2006974744 hasAuthorship W2006974744A5053724616 @default.
• W2006974744 hasAuthorship W2006974744A5067465993 @default.
• W2006974744 hasConcept C104317684 @default.
• W2006974744 hasConcept C126322002 @default.
• W2006974744 hasConcept C143998085 @default.
• W2006974744 hasConcept C150194340 @default.
• W2006974744 hasConcept C190727270 @default.
• W2006974744 hasConcept C2776239401 @default.
• W2006974744 hasConcept C2778461978 @default.
• W2006974744 hasConcept C2778729363 @default.
• W2006974744 hasConcept C2780007613 @default.
• W2006974744 hasConcept C2780817109 @default.
• W2006974744 hasConcept C38180746 @default.
• W2006974744 hasConcept C55493867 @default.
• W2006974744 hasConcept C71924100 @default.
• W2006974744 hasConcept C72563966 @default.
• W2006974744 hasConcept C86803240 @default.
• W2006974744 hasConcept C90924648 @default.
• W2006974744 hasConceptScore W2006974744C104317684 @default.
• W2006974744 hasConceptScore W2006974744C126322002 @default.
• W2006974744 hasConceptScore W2006974744C143998085 @default.
• W2006974744 hasConceptScore W2006974744C150194340 @default.
• W2006974744 hasConceptScore W2006974744C190727270 @default.
• W2006974744 hasConceptScore W2006974744C2776239401 @default.
• W2006974744 hasConceptScore W2006974744C2778461978 @default.
• W2006974744 hasConceptScore W2006974744C2778729363 @default.
• W2006974744 hasConceptScore W2006974744C2780007613 @default.
• W2006974744 hasConceptScore W2006974744C2780817109 @default.
• W2006974744 hasConceptScore W2006974744C38180746 @default.
• W2006974744 hasConceptScore W2006974744C55493867 @default.
• W2006974744 hasConceptScore W2006974744C71924100 @default.

• next